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Abstract 
Blood pressures, serum total cholesterol levels, blood glucose levels, anthropometric parameters and 
ages of five hundred and thirty eight adult Nigerians, living in two localities were measured using 
standard protocol. The mean age of the subjects was 50.5 ± 10.8 years while their mean body mass 
index (BMI) was 24.9 ± 5.0 kg/m
2
. Hypertensive subjects who had desirable serum total cholesterol 
levels had lower systolic blood pressure (SBP) (152.33 ± 19.55 mmHg, for males, and 145.60 ± 18.64 
mmHg, for females) compared to those who had undesirable serum total cholesterol levels (174.02 ± 
24.93 mmHg, for males, and 177.65 ± 31.11 mmHg, for females). For normotensive subjects, serum 
total cholesterol status did not significantly affect SBP. SBP in the hypertensive subjects was highest 
in the overweight group (159.17 ± 25.31 mmHg) and lowest in the obese group (150.69 ± 20.14 
mmHg). In normotensive subjects, SBP did not change markedly between the BMI groups. Data on 
the effects of age and blood glucose levels are presented. Risk factors for hypertension may not affect 
individuals with and without the disorder linearly. The underlying mechanistic processes that link 
changes in these risk factors to their physiological consequences for blood pressure elevation and 
regulation deserve more attention 
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The prevalence of cardiovascular diseases is 
increasing steeply in the developing world and 
may be related to the rapidly aging population, 
changing lifestyles and nutrition transition in 
those regions of the world
1
. Blood pressure 
(BP) is generally accepted to have a role in 
accelerating atherosclerosis of the blood 
vessels and thereby influencing cardiovascular 
disease
2
. Prospective cohort studies have 
demonstrated a strong association between 
blood pressure and stroke, ischaemic heart 
disease, renal disease and other cardiovascular 
diseases
3-7
. Globally high BP is estimated to 
cause 7.1 million deaths, about 13% of the 
total
8
. However, high blood pressure is still 
largely ignored as a public health problem in 
many developing countries
9
, despite the fact 
that such countries are increasingly faced with 
the double burden of hypertension and other 
cardiovascular diseases, along with infection 
and malnutrition
8,10
. Since developing 
countries cannot afford the high cost of 
treating hypertension and its sequelea in large 
portions of their population, appropriate 
preventive measures should be put in place to 
control risk factor levels in the general 
population and in individuals at risk
11
. 
Correlations between body mass index (BMI) 





 and Asian 
16,17
 populations. 
Elevated BP has also been linked to serum 
total cholesterol levels and blood glucose 
levels 
18-20
. In fact, a lot has documented on the 
correlates of blood pressure and its co-morbid 
conditions. However, whether the risk factors 
– age, gender, BMI, serum total cholesterol 
concentration and blood glucose concentration 
– affect hypertensive individuals and 
normotensive individuals alike, has not been 
given appropriate attention, especially in lean 
populations of Africa. This study investigates 
our hypothesis that these risk factors affect 
individuals with and without hypertension 
disproportionately. 
 
SUBJECTS AND METHODS 
 
Nigerian men and women aged 30-74 years 
were studied. The participants were from 
Anyigba (Kogi state) and Nsukka (Enugu 
state) – both states are geographically 
neighbours with Kogi bordering Enugu to the 
North Anyigba and Nsukka are host towns to 
the Kogi State University and the University 
of Nigeria, respectively. The study was 
advertised locally in the two towns and those 
who indicated interest and gave an informed 
consent were allowed to participate in the 
study. 
 
Participants had their blood pressure measured 
using a digital blood pressure monitor (Omron 
model HEM-741 CINT, Omron Healthcare 
Inc., Illinois, USA) between 8am and 10am. 
Three separate readings were taken (after a 
two minutes interval each) per individual (in a 
sitting position after an initial ten minutes rest) 
per day, and the average of the second and 
third readings recorded. Subjects who had a 
mean systolic blood pressure (SBP) ≥ 
140mmHg and/or a mean diastolic blood 
pressure (DBP) ≥ 90 mmHg were re-evaluated 
on a different day, and those who consistently 
had SBP/DBP ≥ 140/90 mmHg, or who 
reported using antihypertensive medication 
were classified as hypertensives (tests)
21
. 
While those with a mean SBP and DBP <140 
and <90 respectively were classified as 
normotensives (controls). 
 
Measurement of weight and height were taken, 
with subjects dressed in light clothing and the 
BMI calculated [weight (kg)/ height (m)
2
]. 
Subjects were grouped as thin (BMI<18,5), 
normal (18.5 ≤ BMI ≤ 24.9), overweight (25 ≤ 




Fasting blood samples (2ml) were drawn from 
each participant using a 4ml syringe, and 
transferred into clean sample containers. A 
drop of whole blood was removed from each 
container immediately and used for the 
measurement of whole blood glucose, using a 
glucometre (Accu-Chek Advantage, Roche 
Diagnostics, Mannheim, Germany). The 
glucometre was calibrated using standard test 
strips and solutions supplied by the 
manufacturer. Blood samples were allowed to 
stand at ambient temperature until clotting 
took place. The serum was separated 
completely by centrifugation for 5 minutes. 
From the serum, the total cholesterol 
concentration was measured by the method of 




Subjects were grouped as having desirable 
serum total cholesterol if they had values 
<5.17mmol/L, and as having undesirable 
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serum total cholesterol if they had values 
≥5.17mmol/L
25
. Subjects who had a fasting 
blood glucose level of >115mg/dL were 
classified as having high blood glucose levels 
while those who had blood glucose levels 
≤115mg/dL were classified as having normal 
blood glucose levels
25
. None of the 
participants presented with hypoglyceamia. 
 
Age at last birthday as reported by each 
participant, was recorded. From that, they 
were grouped in age-ranges of ten years each 
(except for the last age-range) starting from 
30-39years. 
 
The study protocol was prepared in accordance 
with the Helsinki Declaration and was 
approved by the Board of the Department of 
Biochemistry, Kogi State University, Anyigba. 
 
Statistical analysis 
Descriptive statistics was done to get the 
characteristics of the subjects, represented as 
means ± standard deviations. Differences 
between means were checked for significance 
using the one way ANOVA and multiple 
comparison tests. The Pearson’s product 
moment correlation was used to assess 
correlations between variables. Multivariate 
linear regression models were used to examine 
the association between the variables and both 
SBP and DBP. Differences between means, 
and associations/correlations were significant 
at p<0.05. Analyses were performed using 






A total of five hundred and forty two (542) 
subjects participated in the study. The 
characteristics of the studied population are 
shown in Table 1.  
 
SBP correlated positively with age, DBP, 
serum total cholesterol concentration and 
blood glucose concentration. DBP apart from 
correlating with SBP also correlated with the 
same parameters as SBP, as shown in Table 2.  
 
The linear regression model (R
2
 = 0.55) 
however showed that only DBP and serum 
total cholesterol concentration contributed 
(positively) to the increase in SBP; while SBP, 
age and serum total cholesterol concentration 
contributed positively) to the increase in DBP 
(Table 2). 
 






Test (n=200) Control (n=68) Test (n=180) Control (n=94) 
Age (Yrs) 50.5 ± 10.8 52.9 ± 11.6 50.4 ± 12.3 50.1 ± 8.6 46.2 ± 10.4 
SBP (mmHg) 144.8 ± 27.2 156.8 ± 22.5 116.8 ± 8.9 154.3 ± 26.8 120.2 ± 10.6 
DBP (mmHg) 88.1 ± 14.1 93.7 ± 13.3 74.2 ± 8.3 93.6 ± 10.7 75.1 ± 8.1 
BMI (kg/m2) 24.9 ± 5.0 24.9 ± 4.3 24.6 ± 8.7 25.0 ± 5.0 25.0 ± 3.6 
Cholesterol (mmol/L) 3.9 ± 1.4 4.1 ± 1.3 3.0 ± 1.2 4.5 ± 1.3 3.2 ± 1.3 
Glucose (mg/dL) 107.8 ± 53.8 106.1 ± 49.0 95.7 ± 41.9 118.7 ± 65.1 100.0 ± 43.0 
 
 
Table 2: Associations and correlations between variables and SBP and DBP 
 Correlation Regression 
 SBP DBP SBP DBP 
Variable r p r p β SE p β SE p 
Age 0.153 0.000 0.186 0.000 -0.015 0.076 0.631 0.065 0.041 0.031 
BMI 0.039 0.367 0.064 0.137 -0.002 0.160 0.941 0.124 0.086 0.001 
Cholesterol 0.516 0.000 0.463 0.000 0.244 0.673 0.000 0.008 0.373 0.811 
Glucose 0.195 0.000 0.169 0.000 0.034 0.015 0.267 0.629 0.008 0.000 
Sex -0.072 0.097 -0.042 0.252 -0.070 1.625 0.019 -0.007 0.875 0.089 
SBP - - 0.706 0.000 - - - 0.587 0.018 0.000 





Grouping the subjects into test and control 
groups and according to their age-ranges 
showed that SBP increased with age in the 
hypertensive group (from 144.9 ± 15.1 mmHg 
for those aged 30-39 years, to 162.7 ± 22.9 
mmHg for those aged 70-74 years) (Figure 1). 
In the test group, the differences in the mean 
SBP values of those aged 30-39 years 
compared to the others were significant 
(p<0.05).  
For the control group, the differences in the 
mean SBP values of any age-range compared 
to that of any other age-range was not 
significant (p>0.05). 
 
Figure 1: Systolic and Diastolic blood pressures of subjects distributed according to their age ranges.  
 
Figure 2: Systolic and Diastolic blood pressures of subjects distributed according to their serum total 
cholesterol concentrations. 
DBP like SBP increased with age in the 
hypertensive group (from 89.2 ± 8.4 mmHg 
for those aged 30-39 years to 96.3 ± 11.4 
mmHg for those aged 70-74 years. Comparing 
between the mean DBP values for the test 
group showed that the differences between the 
values for those aged 30-39 years and any 
other group (excluding 50-59 years) were 
significant (p<0.05). In the control group, the 
differences in the mean DBP values for any 
age-range compared to any other age-range 
were not significant (p>0.05). Grouping the 
subjects along serum total cholesterol lines 
(for both sexes) in the hypertensive and 
normotensive subjects showed that in both 
male and female hypertensive subjects, those 
who had undesirable serum total cholesterol 





























































































normotensive males and females, SBP did not 
change appreciably with change in serum total 
cholesterol status. DBP in both the 
hypertensive and normotensive subjects 
followed the trend described for SBP. 
 
Figure 3 shows the blood pressures of the 
subjects grouped according to their blood 
glucose levels. Those with high blood glucose 
level in the hypertensive group had higher 
SBP than those with normal blood glucose 
level, especially in male subjects.  
 
For the normotensive subjects, SBP values 
oscillated around 118mmHg for both males 
and females irrespective of their blood glucose 
grouping. DBP however was higher in those 
with high blood glucose level, irrespective of 
sex, and in both hypertensive and 
normotensive subjects.  
 
Comparing the SBP values between the two 
blood glucose groups among the hypertensive 
subjects showed that the differences (within 
each sex) was significant (p<0.05). DBP gave 
similar results. The differences in the mean 
ages of hypertensive subjects with normal 
blood glucose concentrations and those with 
high blood glucose concentrations (within the 
sexes) showed no significance (p>0.05). The 
same was the case with the normotensives. 
 
















































































































Finally, classifying the subjects on the basis of 
their BMI showed that both SBP and DBP 
were higher in the higher BMI groups of the 
normotensives but not the hypertensives 
(Figure 4). In normotensive subjects, the 
changes in mean SBP and DBP for both males 
and females, with respect to the three BMI 
groups were not significant (p>0.05). The 
same was the case in the hypertensive subjects, 
except for the differences between the mean 
DBP of overweight hypertensives compared to 
the obese ones, which was significant 
(p<0.05). There was no significant (p>0.05) 
difference in the mean ages of hypertensive 
subjects who had normal BMI and the others 
(within the sexes). The same trend was 




Taken holistically, our data show that 
increases in age, serum total cholesterol level 
and blood glucose level resulted in increases in 
both systolic and diastolic blood pressures. 
The effects of age and blood glucose were 
weak (r<0.2), while the effects of serum total 
cholesterol was stronger (r>0.5). The 
regression analysis however show that only 
serum cholesterol contributed significantly to 
both SBP and DBP while age contributed 
significantly to only DBP. This disagrees with 
the findings of some researchers reporting an 
association between BP and BMI
14,15,26
, but 
agrees with others who reported associations 





Splitting the subjects up along lines of BP 
status gave clearer insights into the role of the 
studied variables in BP elevations. Among 
hypertensive subjects, both SBP and DBP 
increased marginally with age. While among 
normotensive subjects, SBP dropped from age 
60-69, but DBP kept increasing with age, 
though slightly. Increase in BP was steeper in 
subjects with hypertension as against those 
with normal BP. Age apparently is a factor 
affecting blood pressure elevation. However 
other modifiable factors centering round 
nutrition and lifestyle, which may be 
exacerbated with age, may be more important 
than age as risk factors for BP
27-30
. Increase in 
age beyond 40-49 years, did not significantly 
increase BP in the population we studied. This 
disagrees with researchers who have reported 
an age-related increase in BP even beyond 50 
years of age
31,32
. Other factors not assayed in 
this study may be responsible for this 
discrepancy. 
 
Among subjects with high BP, having 
undesirable cholesterol concentration 
significantly increased both systolic and 
diastolic blood pressures. But serum 
cholesterol concentration had little or no effect 
on the SBP and DBP of subjects with normal 
BP. The exact mechanisms, by which 
cholesterol results in elevated BP, accelerate 
atherosclerosis and influence cardiovascular 
diseases are unclear. It has been suggested that 
cholesterol, particularly low density 
lipoprotein (LDL) cholesterol which accounts 
for about 60% of total cholesterol in 
circulation is taken up by macrophages. At 
high (undesirable) levels of cholesterol, 
macrophages take up more cholesterol than 
they can metabolize and then become ‘foam 
cells’. These cells play important roles in 
atheromatous plaque formation and the 
subsequent narrowing of blood vessel 
walls
33,34
. It appears serum cholesterol levels 
may be a risk factor for elevated BP only in 
subjects already hypertensive. The reason for 
this disproportionate response of BP to serum 
cholesterol levels is not clear to us. 
 
Hypertensive subjects who had high blood 
glucose levels had higher SBP and DBP than 
those with normal blood glucose levels. The 
differences were wider in the male than in the 
female subjects. However, in subjects with 
normal BP, the differences in the SBP and 
DBP of the two blood glucose sub-sets were 
both negligible and insignificant. Sustained 
blood glucose elevation could lead to diabetes 
mellitus which often follows obesity (from 
imbalances in energy intake and expenditure) 
and may result in altered insulin 
response/sensitivity
35
. Insulin-resistant persons 




interrelationship may explain the atherogenic 
effects of glucose. It may also explain our 
observation that blood glucose levels affected 
BP in the same manner as serum total 
cholesterol, in this study. 
 
BMI is widely said to correlate with BP
14,15,26
. 
Our study shows that among subjects with 
hypertension, SBP was lowest in the obese 
91 
 
males while that of the females differed very 
negligibly with increasing BMI. The same 
trend was noticed for DBP. However, among 
the control subjects, BP increased with 
increasing BMI, though not significantly. 
Interpreting data on BMI is rather difficult. For 
most people, BMI provides a good measure of 
obesity, but does not provide actual 
information on body composition – the 
proportions of muscle, bone, fat and other 
tissues that make up a person’s total body 
weight
37
. Increasing weight has been shown to 
increase salt retention
38
, reduce physical 
activity
39
 and lead to insulin resistance
15
. 
These are hypothesized to be the aspects of the 
major mechanisms by which increasing BMI 
influences BP. BMI may therefore be a proxy 
for other causal exposures. Our data shows 
that in the studied population, which is lean 
(average BMI 24.9), increasing BMI did not 
result in significant increases in BP. Other 
factors like genetics, diet, hormonal changes, 
physical activity, sodium metabolism, which 
the present study could not assess may be at 
play in the population. The regression models 
explained 55% of the studied variables (R
2
 = 
0.53) leaving an unexplained 45%. It would 
appear from our data that BMI could be some 
cause of worry (from the point of high BP) 
only to those with normal blood pressures. 
 
Blood pressure increased (though not 
significantly) with age in both hypertensive 
and normotensive subjects. Elevations in 
serum total cholesterol and blood glucose 
levels increased BP significantly only in 
hypertensive subjects. Increases in BMI 
however increased BP marginally in 
normotensive, but not hypertensive subjects. 
These results therefore support our hypothesis 
that risk factors for hypertension and 
cardiovascular diseases affect hypertensive 
and normotensive individuals 
disproportionately.  
 
This study may be limited by sampling bias, as 
possibly those who knew they were 
hypertensive and were already managing it 
presented themselves for the study. This may 
explain the reason we had more hypertensive 
participants than normotensive ones. Our 
sample size is also not very large, warranting 
not just a careful interpretation of the data, but 
also testing the results in larger samples. BP 
values in our study may be lower than they 
would have been if we used mercury 
manometers. Automated devices tend to give 
lower BP values compared to mercury 
devices
40
. Nevertheless, the rigorous method 
we adopted for BP measurements per test 
subject make this study very informative of the 
population we studied. We have taken the 
investigation into the relationship between BP 
and some other cardiovascular risk factors and 
our results have important clinical and public 
health implications. We therefore suggest that 
the underlying mechanistic processes that link 
changes in these variables to their 
physiological consequences for BP elevation 
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